5:56 PM
 | 
Jun 19, 2013
 |  BC Extra  |  Company News

Advisory committee planned for Vascepa sNDA

Amarin Corp. plc (NASDAQ:AMRN) said FDA notified the company that an advisory committee will meet on Oct. 16 to discuss an sNDA for hypertriglyceridemia drug Vascepa icosapent ethyl....

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >